CTKB - Cytek BioSciences Inc
IEX Last Trade
5.735
0.045 0.785%
Share volume: 489,773
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.69
0.05
0.79%
Fundamental analysis
12%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
10%
Performance
5 Days
1.59%
1 Month
-13.68%
3 Months
1.06%
6 Months
-34.32%
1 Year
-24.67%
2 Year
-50.47%
Key data
Stock price
$5.74
DAY RANGE
$5.65 - N/A
52 WEEK RANGE
$3.80 - $9.87
52 WEEK CHANGE
-$0.26
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Wenbin Jiang
Region: US
Website: https://www.cytekdev.com/
Employees: 555
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.cytekdev.com/
Employees: 555
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Cytek Biosciences, Inc. is a life sciences technology company engaged in the provision of cell analysis tools by leveraging novel technical approaches.
Recent news